Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Daniel Kuritzkes"'
Autor:
Michael M. Lederman, Jeffrey Flier, Peter Hale, Ashley Haase, William Powderly, Peter Reiss, Guido Silvestri, Rafick Sekaly, Mirko Paiardini, Drew Weissman, Daniel Kuritzkes, Leonard Calabrese, Peter Agre, Gustavo Reyes-Teran, Alan Landay, Sharon Lewin, Douglas Richman, Paul Volberding, Peter Hunt, Mauro Schechter
Publikováno v:
Pathogens and Immunity, Vol 6, Iss 2 (2021)
On September 10, 2021, a special tribunal established by the French government launched an inquiry into the activities of former health minister Dr. Agnes Buzyn who was charged with “endangering the lives of others”. It is surprising to learn of
Externí odkaz:
https://doaj.org/article/e49ede9741cd4510a3ab9c62eeb806a3
Autor:
Daniel Kuritzkes
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss , Pp 5- (2016)
Externí odkaz:
https://doaj.org/article/e1930e29c6c6409eafbd9baac21e9786
Autor:
Nicholas T Funderburg, Adriana Andrade, Ellen S Chan, Susan L Rosenkranz, Darlene Lu, Brian Clagett, Heather A Pilch-Cooper, Benigno Rodriguez, Judith Feinberg, Eric Daar, John Mellors, Daniel Kuritzkes, Jeffrey M Jacobson, Michael M Lederman
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83514 (2013)
The dynamics of CD4+ T cell reconstitution and changes in immune activation and inflammation in HIV-1 disease following initiation of antiretroviral therapy (ART) are incompletely defined and their underlying mechanisms poorly understood.Thirty-nine
Externí odkaz:
https://doaj.org/article/3b58f04f006740d5be4622a96fcb8721
Autor:
Eric S Rosenberg, Barney S Graham, Ellen S Chan, Ronald J Bosch, Vicki Stocker, Janine Maenza, Martin Markowitz, Susan Little, Paul E Sax, Ann C Collier, Gary Nabel, Suzanne Saindon, Theresa Flynn, Daniel Kuritzkes, Dan H Barouch, AIDS Clinical Trials Group A5187 Team
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10555 (2010)
An effective therapeutic vaccine that could augment immune control of HIV-1 replication may abrogate or delay the need for antiretroviral therapy. AIDS Clinical Trials Group (ACTG) A5187 was a phase I/II, randomized, placebo-controlled, double-blinde
Externí odkaz:
https://doaj.org/article/790158474e81421abf26201fb037c5db
Autor:
Andrew N, Phillips, Francois, Venter, Diane, Havlir, Anton, Pozniak, Daniel, Kuritzkes, Annemarie, Wensing, Jens D, Lundgren, Andrea, De Luca, Deenan, Pillay, John, Mellors, Valentina, Cambiano, Loveleen, Bansi-Matharu, Fumiyo, Nakagawa, Thokozani, Kalua, Andreas, Jahn, Tsitsi, Apollo, Owen, Mugurungi, Polly, Clayden, Ravindra K, Gupta, Ruanne, Barnabas, Paul, Revill, Jennifer, Cohn, Silvia, Bertagnolio, Alexandra, Calmy
Publikováno v:
The Lancet HIV, 6(2), e116. Elsevier Limited
The lancet. HIV, vol 6, iss 2
Phillips, A N, Venter, F, Havlir, D, Pozniak, A, Kuritzkes, D, Wensing, A, Lundgren, J D, De Luca, A, Pillay, D, Mellors, J, Cambiano, V, Bansi-Matharu, L, Nakagawa, F, Kalua, T, Jahn, A, Apollo, T, Mugurungi, O, Clayden, P, Gupta, R K, Barnabas, R, Revill, P, Cohn, J, Bertagnolio, S & Calmy, A 2019, ' Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa : a modelling study ', The Lancet HIV, vol. 6, no. 2, pp. e116-e127 . https://doi.org/10.1016/S2352-3018(18)30317-5
The lancet. HIV, vol 6, iss 2
Phillips, A N, Venter, F, Havlir, D, Pozniak, A, Kuritzkes, D, Wensing, A, Lundgren, J D, De Luca, A, Pillay, D, Mellors, J, Cambiano, V, Bansi-Matharu, L, Nakagawa, F, Kalua, T, Jahn, A, Apollo, T, Mugurungi, O, Clayden, P, Gupta, R K, Barnabas, R, Revill, P, Cohn, J, Bertagnolio, S & Calmy, A 2019, ' Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa : a modelling study ', The Lancet HIV, vol. 6, no. 2, pp. e116-e127 . https://doi.org/10.1016/S2352-3018(18)30317-5
BACKGROUND: The integrase inhibitor dolutegravir could have a major role in future antiretroviral therapy (ART) regimens in sub-Saharan Africa because of its high potency and barrier to resistance, good tolerability, and low cost, but there is uncert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1474a6eda84c0a8cec7d8d80ba3c3879
https://dspace.library.uu.nl/handle/1874/392221
https://dspace.library.uu.nl/handle/1874/392221
Autor:
Alan L, Landay, John, Spritzler, Harold, Kessler, Donna, Mildvan, Minya, Pu, Larry, Fox, Dorothy, O'Neil, Barbara, Schock, Daniel, Kuritzkes, Michael M, Lederman
Publikováno v:
The Journal of Infectious Diseases. 188:1444-1454
We compared immune restoration in patients who suppressed human immunodeficiency virus type 1 replication after treatment with a protease inhibitor (PI) plus nevirapine or with 3 nucleoside reverse-transcriptase inhibitors (NRTIs) plus nevirapine. Ch
Publikováno v:
AIDS (London, England). 18
Publikováno v:
Antiviral therapy. 8(1)
Despite evidence for the role of adipocyte-derived hormones in insulin resistance, little is known about their levels in human lipodystrophic states. We examined the relationships of plasma leptin and adiponectin levels to fat distribution and insuli
Autor:
Daniel, Kuritzkes
Publikováno v:
The AIDS reader. 12(9)
Treatment failure due to the rise of drug-resistant viral strains remains a serious problem confronting HIV treaters and patients alike. Among patients receiving antiretroviral therapy for HIV infection, new mutations associated with drug resistance
Publikováno v:
Nature Reviews Drug Discovery. 7:15-16